Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

research The effect of polyphloretin phosphate, polyoestradiol phosphate, a diphosphonate and a polyphosphate on calcification induced by dihydrotachysterol in skin, aorta and kidney of rats

31 citations , February 1972 in “Experientia”

The diphosphonate was the most effective at preventing calcification in rats.

research Use of Myoinositol in PCOS

September 2025 in “Obstetrics and gynecology.”

Myoinositol effectively manages PCOS with fewer side effects than metformin.

Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin, or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients

research Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.

16 citations , November 2020 in “Research Square (Research Square)”

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

research The Fabrication of Different Concentrations of Solid Lipid Nanoparticles of Finasteride

January 2011 in “Hebei yixue”

The 0.1% finasteride nanoparticles are efficient, uniform, and stable.

research Lung-Targeted Delivery of Cepharanthine by an Erythrocyte-Anchoring Strategy for the Treatment of Acute Lung Injury

8 citations , August 2022 in “Pharmaceutics”

Erythrocyte-anchored nanoparticles improved Cepharanthine delivery and effectiveness for treating acute lung injury.

research How useful is ritlecitinib in alopecia areata?

July 2025 in “Zenodo (CERN European Organization for Nuclear Research)”

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

UK High Court Revokes Escitalopram Patent; Validity of Second Medical Use Claims Based on Dosage Regimes; Stay of Proceedings Pending EPO Opposition

research UK High Court Revokes Escitalopram UK Patent; Validity of Second Medical use Claims Based on Dosage Regimes in the UK; Stay of Proceedings in the UK Courts Pending EPO Opposition Proceedings

July 2007 in “Journal of Generic Medicines”

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

The Relative Efficacy of Monotherapy With Janus Kinase Inhibitors, Dupilumab and Apremilast in Adults With Alopecia Areata: Network Meta-Analyses of Clinical Trials

research The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials

2 citations , July 2023 in “Journal of cosmetic dermatology”

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Steroid Sulfatase Inhibitors: Therapeutic Applications and Development

research Steroid sulfatase inhibitors

25 citations , May 2003 in “Expert Opinion on Therapeutic Patents”

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

research 1370 MTORC1 activity is increased in the skin of acne patients and is suppressed with isotretinoin treatment

April 2023 in “Journal of Investigative Dermatology”

Acne patients have higher skin mTORC1 activity, which is reduced by isotretinoin treatment.

← Previous page